"
Metformin: A possible drug for treatment of endometrial cancer"
written by Kosuke Tsuji, Iori Kisu, Kouji Banno, Megumi Yanokura, Arisa Ueki, Kenta Masuda, Yusuke Kobayashi, Wataru Yamagami, Hiroyuki Nomura, Nobuyuki Susumu, Daisuke Aoki,
published by
Open Journal of Obstetrics and Gynecology,
Vol.2 No.1, 2012
has been cited by the following article(s):
|
[1]
|
Polyphosphate, the physiological metabolic fuel for corneal cells: a potential biomaterial for ocular surface repair
|
|
2019 |
|
|
|
|
[2]
|
Metformin reverses the resistance mechanism of lung adenocarcinoma cells that knocks down the Nrf2 gene
|
|
2018 |
|
|
|
|
[3]
|
Linking type 2 diabetes and gynecological cancer: an introductory overview
|
|
Clinical Chemistry and Laboratory Medicine (CCLM),
2018 |
|
|
|
|
[4]
|
Why Metformin Is so Important for Prevention and Therapy in Climacteric Women
|
|
Pre-Menopause, Menopause and Beyond,
2018 |
|
|
|
|
[5]
|
Pre-Menopause, Menopause and Beyond Volume 5: Frontiers in Gynecological Endocrinology
|
|
ISGE Series book series (ISGE),
2018 |
|
|
|
|
[6]
|
Efficacy of metformin for advanced-stage endometrial cancer: A case report
|
|
2017 |
|
|
|
|
[7]
|
二甲双胍对子宫内膜癌的抗肿瘤作用及对其生存期的影响
|
|
肿瘤预防与治疗,
2016 |
|
|
|
|
[8]
|
Insulin-like growth factor 1/mammalian target of rapamycin and AMP-activated protein kinase signaling involved in the effects of metformin in the human endometrial …
|
|
International Journal of Gynecological Cancer,
2016 |
|
|
|
|
[9]
|
二甲双胍治疗 2 型糖尿病合并子宫内膜癌的研究进展
|
|
疑难病杂志,
2016 |
|
|
|
|
[10]
|
Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning (Review)
|
|
Oncology Letters,
2016 |
|
|
|
|
[11]
|
Systemic Treatment of Advanced Endometrial Carcinoma
|
|
Uterine Cancer,
2015 |
|
|
|
|
[12]
|
Contact lens sensors in ocular diagnostics
|
|
Advanced healthcare materials,
2015 |
|
|
|
|
[13]
|
New candidate therapeutic agents for endometrial cancer: potential for clinical practice
|
|
2013 |
|
|
|
|
[14]
|
New candidate therapeutic agents for endometrial cancer: Potential for clinical practice (Review)
|
|
Oncology reports,
2013 |
|
|
|
|
[1]
|
Pre-Menopause, Menopause and Beyond
ISGE Series,
2018
DOI:10.1007/978-3-319-63540-8_11
|
|
|
|
|
[2]
|
Metformin reverses the resistance mechanism of lung adenocarcinoma cells that knocks down the Nrf2 gene
Oncology Letters,
2018
DOI:10.3892/ol.2018.9382
|
|
|
|
|
[3]
|
Linking type 2 diabetes and gynecological cancer: an introductory overview
Clinical Chemistry and Laboratory Medicine (CCLM),
2018
DOI:10.1515/cclm-2017-0982
|
|
|
|
|
[4]
|
Efficacy of metformin for advanced-stage endometrial cancer: A case report
Molecular and Clinical Oncology,
2017
DOI:10.3892/mco.2017.1130
|
|
|
|
|
[5]
|
Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning
Oncology Letters,
2016
DOI:10.3892/ol.2016.4075
|
|
|
|
|
[6]
|
Insulin-Like Growth Factor 1/Mammalian Target of Rapamycin and AMP-Activated Protein Kinase Signaling Involved in the Effects of Metformin in the Human Endometrial Cancer
International Journal of Gynecological Cancer,
2016
DOI:10.1097/IGC.0000000000000818
|
|
|
|
|
[7]
|
Uterine Cancer
2015
DOI:10.1007/978-81-322-1892-0_28
|
|
|
|
|
[8]
|
Uterine Cancer
2015
DOI:10.1007/978-81-322-1892-0_28
|
|
|
|
|
[9]
|
New candidate therapeutic agents for endometrial cancer: Potential for clinical practice (Review)
Oncology Reports,
2013
DOI:10.3892/or.2013.2221
|
|
|
|